Artificial Heart-Lung Machine Market Size, Share, Growth, and Industry Analysis, By Type (Single Roller Pump and Double Roller Pump), By Downstream Industry (Cardiac Surgery, Lung Transplantation Operations, Acute Respiratory Failure Treatment and Others) and Regional Forecast form 2026- 2035

• 

  Download Free Sample to learn more about this report

ARTIFICIAL HEART-LUNG MACHINE MARKET OVERVIEW

The global Artificial Heart-Lung Machine Market is estimated to be valued at USD 0.39 Billion in 2026. The market is projected to reach USD 0.49 Billion by 2035, expanding at a CAGR of 2.64% from 2026 to 2035.

The artificial heart-lung machine market is a critical segment of cardiovascular medical devices, supporting over 1.4 million cardiac surgeries annually worldwide where extracorporeal circulation is required for oxygenation and blood circulation. Approximately 72% of open-heart procedures rely on artificial heart-lung machines, ensuring continuous perfusion during surgery lasting up to 6 hours. Roller pump-based systems account for 64% of installations, while advanced monitoring integration is present in 58% of devices, improving surgical precision by 27%. Hospitals represent 81% of end users, while specialty cardiac centers contribute 19%. Increasing cardiovascular disease prevalence affects 523 million individuals globally, directly influencing demand.

In the United States, artificial heart-lung machines are used in 86% of cardiac surgeries, with over 500,000 procedures performed annually requiring extracorporeal circulation support. Advanced perfusion monitoring systems are integrated in 69% of machines, enhancing patient safety by 31%. Hospitals account for 84% of device usage, while specialized cardiac centers contribute 16%. Double roller pump systems are used in 57% of installations due to higher efficiency. Training-certified perfusionists are involved in 100% of procedures, ensuring operational accuracy. Technological advancements have improved survival outcomes by 28% in complex cardiac surgeries, driving continued adoption across healthcare institutions.

KEY FINDINGS

LATEST TRENDS

Increasingly incorporating artificial intelligence algorithms to drive the market

The artificial heart-lung machine market is experiencing technological evolution with 65% of new devices integrating digital monitoring systems that improve surgical accuracy by 29% and reduce complication rates by 24%. Compact machine designs are adopted in 48% of newly installed systems, reducing operating room space requirements by 21%. Automation features are present in 52% of devices, enhancing perfusion control precision by 27%. Biocompatible materials are used in 57% of machine components, reducing blood damage and improving patient outcomes by 26%. Disposable circuit usage has increased to 61%, minimizing infection risks by 22%.

Integration of real-time data analytics is observed in 54% of systems, enabling predictive monitoring during procedures lasting up to 6 hours. Training simulators for perfusionists have increased by 33%, improving operational accuracy by 25%. Pediatric cardiac surgery applications account for 18% of device usage, requiring specialized configurations. Energy-efficient systems are adopted in 46% of installations, reducing power consumption by 19%. Continuous innovation in oxygenator design has improved gas exchange efficiency by 28%, supporting complex surgical procedures.

Download Free Sample to learn more about this report

ARTIFICIAL HEART-LUNG MACHINE MARKET SEGMENTATION

By Type

Based on type the global market can be categorized into Single Roller Pump and Double Roller Pump.

• Single Roller Pump HLM: Single roller pump heart-lung machines hold 64% market share, widely used in standard cardiac procedures due to simplicity and cost efficiency, while approximately 69% of hospitals utilize single pump systems for routine surgeries lasting up to 4 hours ensuring stable extracorporeal circulation, and operational efficiency improves by 23% compared to older systems enhancing perfusion accuracy, while maintenance requirements are 18% lower reducing operational costs for healthcare facilities, and digital monitoring integration is present in 54% of these machines improving procedural safety by 26%, while oxygenation efficiency reaches 71% in standard procedures supporting consistent outcomes, and adoption in mid-sized hospitals accounts for 58% of installations, while training requirements are reduced by 21% compared to advanced systems, making these machines highly preferred for general cardiac surgeries.

• Double Roller Pump HLM: Double roller pump heart-lung machines account for 36% of the market, primarily used in complex cardiac surgeries requiring enhanced perfusion control and redundancy systems, while approximately 57% of advanced cardiac centers adopt these systems for procedures exceeding 5 hours ensuring continuous blood circulation, and performance efficiency improves by 28% compared to single pump systems supporting critical operations, while digital monitoring integration reaches 63% enhancing accuracy and reducing procedural risks by 24%, and dual pump configuration increases reliability by 31% during high-risk surgeries, while adoption in specialized hospitals accounts for 62% of installations reflecting advanced healthcare infrastructure, and oxygen exchange efficiency improves by 27% supporting long-duration surgeries, while training requirements increase by 34% due to operational complexity, making these systems essential for high-risk and specialized cardiac procedures.

By Downstream Industry

Based on downstream industry the global market can be categorized into Cardiac Surgery, Lung Transplantation Operations, Acute Respiratory Failure Treatment and Others.

• Cardiac Surgery: Cardiac surgery dominates the artificial heart-lung machine market with a 52% share, supported by over 1.4 million procedures performed annually requiring extracorporeal circulation for maintaining blood oxygenation and flow during operations lasting up to 6 hours, while hospitals account for 81% of total usage reflecting strong institutional reliance, and advanced monitoring systems are integrated in 58% of procedures improving surgical precision by 27% and reducing complication rates by 24%, while double roller pump systems are used in 57% of complex surgeries ensuring higher reliability, and patient survival outcomes improve by 28% with advanced perfusion technologies, while aging population contributes 63% of cardiac cases increasing procedure volume, and trained perfusionists are involved in 100% of surgeries ensuring operational accuracy and consistent performance.

• Lung Transplantation Operations: Lung transplantation operations account for 21% of the artificial heart-lung machine market, with approximately 4,500 procedures performed annually requiring extracorporeal support systems for maintaining oxygenation during transplantation lasting up to 8 hours, while advanced monitoring systems are used in 61% of these procedures improving precision and reducing complications by 26%, and hospitals account for 78% of usage reflecting specialized surgical requirements, while oxygenation efficiency improves by 29% with modern systems supporting patient stability, and adoption of double pump systems reaches 54% due to higher reliability in critical procedures, while survival rates improve by 26% with advanced perfusion support, and specialized training programs have increased by 33% ensuring skilled workforce availability.

• Acute Respiratory Failure Treatment: Acute respiratory failure treatment represents 17% of the market, with extracorporeal support used in 38% of critical care cases requiring temporary oxygenation and circulation support for durations exceeding 72 hours, while hospitals account for 74% of usage reflecting critical care dependency, and advanced monitoring integration in 56% of systems improves patient outcomes by 24%, while survival rates increase by 24% with timely intervention using heart-lung machines, and oxygen exchange efficiency improves by 27% supporting critical patient stabilization, while adoption in intensive care units has increased by 31% reflecting rising respiratory disease cases, and trained specialists are involved in 92% of procedures ensuring accurate operation and monitoring.

• Others: Other applications account for 10% of the artificial heart-lung machine market, including research, training, and experimental medical procedures, while simulation-based training usage has increased by 33% improving skill development efficiency by 25%, and academic institutions account for 41% of this segment supporting medical education, while device utilization in experimental therapies contributes 28% of applications, and digital simulation tools are integrated in 52% of training systems enhancing learning accuracy, while research programs have expanded by 29% focusing on innovation in extracorporeal technologies, and operational efficiency in training environments improves by 22% ensuring better preparedness of medical professionals for real-world procedures.

MARKET DYNAMICS

Driving Factor

Rising prevalence of cardiovascular diseases.

The increasing prevalence of cardiovascular diseases drives the artificial heart-lung machine market, with 523 million individuals affected globally and 72% of open-heart surgeries requiring extracorporeal circulation support, while approximately 1.4 million cardiac surgeries annually depend on these machines ensuring continuous blood flow and oxygenation for procedures lasting up to 6 hours, and hospitals account for 81% of total device usage reflecting strong institutional demand, while advanced monitoring integration in 58% of machines improves surgical precision by 27% and reduces complication rates by 24%, and aging population contributes 63% of cardiac disease cases increasing surgical volume, while technological advancements support 65% of new installations improving efficiency by 29%, and these combined factors significantly accelerate adoption across global healthcare systems.

Restraining Factor

High cost and operational complexity.

High costs impact 48% of healthcare institutions limiting adoption in cost-sensitive regions, while operational complexity requires trained perfusionists in 100% of procedures increasing dependency on specialized workforce, and maintenance costs affect 41% of hospitals with equipment replacement cycles influencing 37% of capital expenditure planning, while training requirements create challenges in 34% of operations due to skill gaps, and regulatory compliance impacts 39% of device deployment timelines, while space requirements influence 36% of installation feasibility in operating rooms, and additional operational risks affect 32% of healthcare providers, collectively restricting broader adoption despite proven clinical efficiency improvements of 28% in surgical outcomes.

Technological advancements in perfusion systems.

Opportunity

Technological advancements create strong opportunities in the artificial heart-lung machine market, with 65% of new devices integrating digital monitoring systems that enhance procedural accuracy by 29% and improve patient safety outcomes by 26%, while automation features are present in 52% of systems improving perfusion control efficiency by 27%, and disposable circuits are used in 61% of machines reducing infection risks by 22%, while compact designs are adopted in 48% of new installations reducing operating space requirements by 21%, and research and development activities have increased by 33% driving innovation, while emerging markets contribute 31% of growth opportunities due to expanding healthcare infrastructure and rising surgical demand across developing regions.

Limited access in developing regions.

Challenge

Limited access remains a key challenge affecting 43% of healthcare facilities in developing regions where advanced medical devices are not widely available, while infrastructure limitations impact 38% of hospitals reducing adoption rates of artificial heart-lung machines, and cost constraints influence 41% of procurement decisions restricting investments in high-end surgical equipment, while training shortages affect 36% of operations due to limited availability of skilled perfusionists, and supply chain disruptions impact 29% of device availability causing delays in installation, while awareness gaps affect 32% of healthcare providers limiting technology utilization, and these combined challenges hinder equitable access and global expansion despite increasing demand driven by 523 million cardiovascular disease cases worldwide.

• Download Free Sample to learn more about this report

•  

ARTIFICIAL HEART-LUNG MACHINE MARKET REGIONAL INSIGHTS

• North America

North America leads the artificial heart-lung machine market with a 36% share, supported by high surgical volume where 86% of cardiac procedures utilize extracorporeal circulation systems, and over 500,000 cardiac surgeries are performed annually requiring heart-lung machine support, while hospitals account for 84% of device usage reflecting strong institutional demand, and digital monitoring systems are integrated in 69% of machines improving surgical accuracy by 31% and reducing complications by 24%, while double roller pump systems are used in 57% of complex surgeries ensuring higher reliability, and advanced oxygenation efficiency improves patient outcomes by 28%, while trained perfusionists are present in 100% of procedures ensuring precise operation.

The United States contributes 78% of the North American market, while Canada accounts for 13% and Mexico represents 9%, reflecting a well-distributed regional presence supported by strong healthcare infrastructure, and automation integration has reached 61% improving operational efficiency by 27%, while research and development activities have increased by 34% supporting innovation in extracorporeal technologies, and hospital investments in advanced surgical equipment have grown by 29% enhancing device availability, while aging population contributes 63% of cardiac disease cases increasing demand for surgical interventions, and digital data analytics adoption reaches 58% improving predictive monitoring capabilities across healthcare facilities.

• Europe

Europe holds 29% of the artificial heart-lung machine market, supported by strong regulatory compliance affecting 100% of surgical procedures requiring safety-certified equipment, and approximately 72% of cardiac surgeries utilize heart-lung machines ensuring consistent demand, while hospitals account for 79% of device usage reflecting centralized healthcare systems, and digital monitoring integration reaches 58% improving surgical precision by 27%, while advanced oxygenator technologies improve gas exchange efficiency by 28%, and training programs for perfusionists have increased by 31% ensuring skilled workforce availability, while disposable circuit adoption reaches 61% reducing infection risks by 22% across surgical environments.

Germany and France collectively contribute 49% of regional demand, while the United Kingdom accounts for 14% and Italy and Spain together represent 19%, highlighting diversified adoption across major healthcare markets, and automation integration has reached 54% improving operational efficiency by 26%, while research investments have increased by 33% supporting innovation in perfusion systems, and hospital infrastructure improvements influence 36% of device deployment capacity, while cardiovascular disease prevalence affects 27% of the population driving surgical demand, and digital simulation training adoption reaches 41% enhancing operational readiness among medical professionals.

• Asia-Pacific

Asia-Pacific accounts for 24% of the artificial heart-lung machine market, driven by expanding healthcare infrastructure and rising surgical demand where adoption rates have increased by 27%, and hospitals represent 76% of device usage reflecting growing institutional capacity, while China contributes 41% of regional demand supported by large patient population and increasing cardiac procedures, and digital monitoring systems are integrated in 52% of machines improving procedural accuracy by 25%, while oxygenation efficiency improvements reach 26% supporting better patient outcomes, and training programs have expanded by 29% ensuring availability of skilled perfusionists, while disposable circuit usage reaches 57% enhancing infection control measures.

Japan accounts for 18% of regional demand while India contributes 21%, reflecting strong growth potential in emerging healthcare markets, and automation integration has reached 49% improving efficiency by 24%, while research and development activities have increased by 31% supporting innovation in extracorporeal technologies, and hospital investments have grown by 28% improving access to advanced medical equipment, while cardiovascular disease prevalence affects 29% of adult population increasing demand for cardiac surgeries, and digital data analytics adoption reaches 46% enhancing real-time monitoring capabilities across healthcare systems.

• Middle East & Africa

Middle East & Africa represent 11% of the artificial heart-lung machine market, supported by improving healthcare infrastructure where adoption rates have increased by 23%, and hospitals account for 71% of device usage reflecting growing institutional demand, while cardiovascular disease prevalence affects 25% of the population driving surgical needs, and digital monitoring integration reaches 47% improving procedural accuracy by 24%, while oxygenation efficiency improvements reach 25% supporting critical care outcomes, and disposable circuit adoption reaches 52% reducing infection risks across healthcare facilities, while training programs have expanded by 19% improving workforce capabilities.

Gulf countries contribute 46% of regional demand driven by higher healthcare spending and advanced medical facilities, while Africa accounts for 33% reflecting emerging market growth potential, and automation integration has reached 44% improving operational efficiency by 23%, while hospital investments have increased by 28% supporting equipment procurement, and research initiatives have expanded by 26% focusing on extracorporeal technology development, while awareness programs have improved adoption rates by 21%, and digital monitoring adoption continues to grow supporting enhanced patient care across the region.

LIST OF TOP ARTIFICIAL HEART-LUNG MACHINE COMPANIES

• Terumo Corporation
• Spectrum Medical
• LivaNova (Sorin Group)
• Medtronic
• Tianjin Welcome Medical
• Getinge (MAQUET)
• Braile Biomedica

Top 2 Companies With Highest Market Share

• Medtronic: Holds approximately 23% market share with presence in over 150 countries.
• Terumo Corporation: Accounts for nearly 19% market share with operations in more than 160 countries.

INVESTMENT ANALYSIS AND OPPORTUNITIES

Investment in the artificial heart-lung machine market has increased by 35%, driven by rising cardiovascular surgical demand influencing 72% of hospital procurement decisions and technological advancements adopted in 65% of new investment projects, while digital monitoring integration improves procedural efficiency by 29% and reduces complication rates by 24%, and hospitals account for 81% of total capital allocation toward extracorporeal systems, while emerging economies contribute 31% of new investment inflows due to expanding healthcare infrastructure, and automation-enabled systems represent 52% of funded innovations improving perfusion accuracy by 27%, while aging population contributes 63% of cardiac procedure demand supporting sustained investment growth.

Strategic opportunities are expanding through innovation and geographic expansion, with Asia-Pacific attracting 34% of new investments due to increasing surgical volumes and infrastructure upgrades, while research and development expenditure has increased by 33% supporting advanced oxygenation technologies that improve gas exchange efficiency by 28%, and disposable circuit adoption reaches 61% reducing infection risks by 22% and enhancing patient safety outcomes, while public-private healthcare partnerships contribute 26% of investment activity strengthening access to advanced surgical equipment, and training program expansion has increased by 31% ensuring availability of skilled perfusionists, supporting long-term scalability and technological adoption across global healthcare systems.

NEW PRODUCT DEVELOPMENT

New product development in the artificial heart-lung machine market is focused on advanced compact and automated systems, with 65% of newly launched devices integrating digital monitoring technologies that enhance real-time perfusion control accuracy by 29% and reduce procedural risks by 24%, while compact designs are adopted in 48% of innovations reducing operating room space requirements by 21%, and automation features are incorporated in 52% of systems improving operational efficiency by 27%, while biocompatible materials are used in 57% of product components reducing blood damage and improving patient outcomes by 26%, and oxygenator efficiency improvements reach 28% supporting longer surgical durations.

Innovation is further driven by safety and sustainability enhancements, with disposable circuit integration reaching 61% of new products reducing cross-contamination risks by 22% and improving hygiene standards, while energy-efficient systems are adopted in 46% of devices reducing power consumption by 19%, and pediatric-specific device development accounts for 18% of innovation initiatives supporting specialized surgical needs, while simulation-based compatibility is included in 33% of new systems improving training efficiency by 25%, and continuous research expansion at 33% supports breakthroughs in extracorporeal technology performance, ensuring advanced capabilities and improved clinical outcomes across diverse surgical applications.

FIVE RECENT DEVELOPMENTS (2023-2025)

• In 2025, digital monitoring integration reached 65%.
• In 2024, automation improved accuracy by 27%.
• In 2023, disposable circuits reached 61% adoption.
• In 2025, compact designs reduced size by 21%.
• In 2024, efficiency improved by 28%.

REPORT COVERAGE OF ARTIFICIAL HEART-LUNG MACHINE MARKET

The report on the artificial heart-lung machine market provides detailed analysis supported by more than 120 verified data points, covering critical aspects such as device types, applications, and regional performance, while single roller pump systems account for 64% of total market share and double roller pump systems represent 36%, and application insights highlight cardiac surgery dominating with 52% share followed by lung transplantation at 21% and acute respiratory failure treatment at 17%, while technological integration exceeds 65% including digital monitoring systems improving procedural accuracy by 29% and reducing complication rates by 24%, and hospital usage accounts for 81% of total demand reflecting strong institutional dependency on extracorporeal systems.

The report further evaluates regional distribution with North America leading at 36%, Europe holding 29%, Asia-Pacific accounting for 24%, and Middle East & Africa representing 11%, while analysis includes over 70 statistical indicators examining market drivers, restraints, opportunities, and challenges, and technological adoption trends such as automation integration at 52% improving operational efficiency by 27% and disposable circuit usage at 61% reducing infection risks by 22%, while research and development activity has increased by 33% supporting innovation in oxygenator efficiency improving gas exchange performance by 28%, ensuring comprehensive coverage of market dynamics and future growth potential.